Perspective Therapeutics raises $87 million on heels of big January round
Seattle-based Perspective Therapeutics Inc. recently raised $87.4 million through a private placement, following a $89.8 million fundraising effort in January. This financing includes acquiring a manufacturing facility in New Jersey from Lantheus Holdings Inc. which also invested $57.4 million in Perspective.
Led by CEO Thijs Spoor, Perspective focuses on delivering radiation to cancer cells and developing imaging diagnostics to improve treatment outcomes. The company’s recent expansion aims to meet the growing clinical trial and commercial demand for its therapies, particularly in the Northeast.
“We are thrilled to expand our manufacturing and supply chain infrastructure to include this facility,” said Spoor.